Dahlquist Karl S.

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return -23% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Dahlquist Karl S.'s trades of AtriCure Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US AtriCure Inc (ATRC)
Transaction date
Sale
Price
396.55
Quantity 74,379 -2.1%
Value US$1,528,812
US AtriCure Inc (ATRC)
Transaction date
Proposed sale
Price
204.57
Quantity 79,806
Value US$1,556,375
US AtriCure Inc (ATRC)
Transaction date
Planned sale
Price
478.81
Quantity 24,222 -17.6%
Value US$4,848,114
US AtriCure Inc (ATRC)
Transaction date
Proposed sale
Price
32.16
Quantity 1,885
Value US$60,622
US AtriCure Inc (ATRC)
Transaction date
Planned sale
Price
37.36
Quantity 8,231 -13.5%
Value US$307,510
US AtriCure Inc (ATRC)
Transaction date
Proposed sale
Price
37.36
Quantity 8,231
Value US$307,529
US AtriCure Inc (ATRC)
Transaction date
Planned sale
Price
34.43
Quantity 1,248 -3.9%
Value US$42,969
US AtriCure Inc (ATRC)
Transaction date
Planned sale
Price
57.09
Quantity 3,417 -9.6%
Value US$195,077
US AtriCure Inc (ATRC)
Transaction date
Proposed sale
Price
57.09
Quantity 3,417
Value US$195,073
US AtriCure Inc (ATRC)
Transaction date
Planned sale
Price
47.03
Quantity 1,422 -3.9%
Value US$66,877
US AtriCure Inc (ATRC)
Transaction date
Proposed sale
Price
47.03
Quantity 1,422
Value US$66,877
US AtriCure Inc (ATRC)
Transaction date
Planned sale
Price
44.83
Quantity 4,417 -10.8%
Value US$198,014
US AtriCure Inc (ATRC)
Transaction date
Proposed sale
Price
44.83
Quantity 4,417
Value US$198,021
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-26 2026-08-24
US AtriCure Inc (ATRC)
S Sale
74,379 -2.1%
396.55
US$1,528,812 		74,379 -2.1% 396.55 US$1,528,812
2026-08-24 2026-08-24
US AtriCure Inc (ATRC)
PrS Proposed sale
79,806
204.57
US$1,556,375 		79,806 204.57 US$1,556,375
2024-03-20 2024-03-18
US AtriCure Inc (ATRC)
PlS Planned sale
24,222 -17.6%
478.81
US$4,848,114 		24,222 -17.6% 478.81 US$4,848,114
2024-03-18 2024-03-18
US AtriCure Inc (ATRC)
PrS Proposed sale
1,885
32.16
US$60,622 		1,885 32.16 US$60,622
2024-03-07 2024-03-05
US AtriCure Inc (ATRC)
PlS Planned sale
8,231 -13.5%
37.36
US$307,510 		8,231 -13.5% 37.36 US$307,510
2024-03-05 2024-03-05
US AtriCure Inc (ATRC)
PrS Proposed sale
8,231
37.36
US$307,529 		8,231 37.36 US$307,529
2023-11-03 2023-11-01
US AtriCure Inc (ATRC)
PlS Planned sale
1,248 -3.9%
34.43
US$42,969 		1,248 -3.9% 34.43 US$42,969
2023-07-28 2023-07-26
US AtriCure Inc (ATRC)
PlS Planned sale
3,417 -9.6%
57.09
US$195,077 		3,417 -9.6% 57.09 US$195,077
2023-07-26 2023-07-26
US AtriCure Inc (ATRC)
PrS Proposed sale
3,417
57.09
US$195,073 		3,417 57.09 US$195,073
2023-06-07 2023-06-06
US AtriCure Inc (ATRC)
PlS Planned sale
1,422 -3.9%
47.03
US$66,877 		1,422 -3.9% 47.03 US$66,877
2023-06-06 2023-06-06
US AtriCure Inc (ATRC)
PrS Proposed sale
1,422
47.03
US$66,877 		1,422 47.03 US$66,877
2023-05-03 2023-05-01
US AtriCure Inc (ATRC)
PlS Planned sale
4,417 -10.8%
44.83
US$198,014 		4,417 -10.8% 44.83 US$198,014
2023-05-01 2023-05-01
US AtriCure Inc (ATRC)
PrS Proposed sale
4,417
44.83
US$198,021 		4,417 44.83 US$198,021